| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 4.54T | 4.74T | 3.97T | 2.30T | 1.37T | 1.41T |
| Gross Profit | 1.78T | 1.65T | 1.38T | 1.14T | 1.14T | 1.20T |
| EBITDA | 529.32B | 533.62B | 335.19B | 210.90B | 286.15B | 294.52B |
| Net Income | 376.36B | 340.74B | 165.86B | 92.79B | 143.00B | 153.12B |
Balance Sheet | ||||||
| Total Assets | 58.10T | 56.80T | 55.15T | 47.77T | 43.41T | 42.52T |
| Cash, Cash Equivalents and Short-Term Investments | 5.55T | 5.07T | 4.24T | 4.52T | 4.06T | 4.16T |
| Total Debt | 30.97T | 31.35T | 30.96T | 26.15T | 10.90T | 9.74T |
| Total Liabilities | 54.51T | 53.22T | 51.70T | 44.55T | 40.44T | 39.76T |
| Stockholders Equity | 3.48T | 3.47T | 3.35T | 3.15T | 2.91T | 2.69T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -868.58B | -13.14B | -1.15T | -974.16B | 545.89B |
| Operating Cash Flow | 0.00 | -678.61B | 132.64B | -974.75B | -862.83B | 665.77B |
| Investing Cash Flow | 0.00 | -848.65B | -887.94B | 38.95B | -593.18B | -139.03B |
| Financing Cash Flow | 0.00 | 1.68T | 1.01T | 1.29T | 1.11T | -269.93B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥199.56B | 6.74 | ― | 4.01% | -2.39% | -4.54% | |
76 Outperform | ¥217.85B | 12.40 | 26.65% | 4.00% | 10.37% | 18.68% | |
76 Outperform | ¥2.09T | 10.19 | 9.37% | 4.13% | -0.87% | 6.88% | |
74 Outperform | ¥245.23B | 12.14 | 14.00% | 5.13% | 3.27% | -1.81% | |
69 Neutral | ¥3.76T | 10.42 | 10.23% | 3.93% | -2.45% | 35.60% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
43 Neutral | ¥171.33B | 13.27 | 7.26% | 4.16% | 14.69% | -114.36% |